Where options run out, BRIA-ABC bets on survival in metastatic breast cancer
Where options run out, BRIA-ABC bets on survival in metastatic breast cancer Clinical Trials Arena
Where options run out, BRIA-ABC bets on survival in metastatic breast cancer Clinical Trials Arena
For ophthalmologists, occupational pain can start early. For Cynthia Matossian, MD, FACS, discomfort arose fewer than 5 years into her career. She said surgeons often find themselves in similar positions over the course of their routine work, and repeated motions can wear people down. “There were two areas that I…
Gastric Cancer Pipeline 2026: FDA Approvals, Therapies, Clinical Trials, and Latest Developments Unveiled by DelveInsight | Eli Lilly and Company, BeiGene, Hutchison MediPharma, Astellas Pharma StreetInsider
Dartmouth Cancer Center Director Roy S. Herbst Elected to National Academy of Medicine Dartmouth Geisel School of Medicine
Havah Therapeutics Urges FDA to Recognize the Breast Cancer Treatment Potential of Androgen Receptor Activation BioSpace
Woman's Doctor: A new kind of cancer treatment in trials WBAL-TV
Dana-Farber, Beth Israel to begin construction of new $1.68 billion cancer hospital The Boston Globe
Лечение остеосаркомы в Израиле: современные методы, диагностика и прогноз ZNAJ.ORG
New UI clinic pilots exercise treatments to improve health of cancer patients, survivors KCRG
Ученые создали противораковое «оружие» из привычного овоща NEWS.ru
A thyroglobulin of 2.5 ng/mL or less may not be enough to determine cancer remission for adults with low-intermediate- or intermediate-high-risk thyroid cancer, according to study data. As Healio previously reported, the American Thyroid Association published an updated guideline on the management of differentiated…
Havah Therapeutics Urges FDA to Recognize the Breast Cancer Treatment Potential of Androgen Receptor Activation Yahoo Finance
Подмосковный врач Баданян: ожирение провоцирует рак молочных желез у мужчин 360.ru
Онколог назвала самое опасное заблуждение о раке груди Radio1.ru